Sheri Spunt

Endowed Professor of Pediatric Cancer

Sarcoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: UCLA (1994) CA

Board Certification: Pediatrics, American Board of Pediatrics (1995)

Board Certification: Hematology/Oncology, American Board of Pediatrics (1998)

Fellowship: Johns Hopkins School of Medicine (1998) MD

Medical Education: University of Michigan (1992) MI

Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group
Spunt, S. L., Smith, L. M., Ruymann, F. B., Qualman, S. J., Donaldson, S. S., & Link, M. P. (2004). Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group. CLINICAL CANCER RESEARCH, 10(18), 6072-6079.

Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
Sung, L., Anderson, J. R., Donaldson, S. S., Spunt, S. L., Crist, W. M., & Pappo, A. S. (2004). Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. EUROPEAN JOURNAL OF CANCER, 40(12), 1878-1885.